Thomas Shrader
Stock Analyst at BTIG
(3.92)
# 1,889
Out of 5,125 analysts
740
Total ratings
38.2%
Success rate
5%
Average return
Main Sectors:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLSA Tiziana Life Sciences | Maintained: Buy | $7 | $0.6691 | +946.18% | 5 | Nov 10, 2026 | |
| CMPS COMPASS Pathways | Maintained: Buy | $25 | $9.18 | +172.33% | 17 | Nov 10, 2026 | |
| ARCT Arcturus Therapeutics Holdings | Reiterated: Buy | $20 | $9.49 | +110.75% | 15 | Nov 6, 2026 | |
| ALEC Alector | Reiterated: Buy | $6 | $2.46 | +143.90% | 28 | Nov 5, 2026 | |
| NVAX Novavax | Reiterated: Buy | $19 | $10.89 | +74.47% | 9 | Nov 5, 2026 | |
| ACIU AC Immune | Reiterated: Buy | $8 | $2.44 | +227.87% | 9 | Nov 4, 2026 | |
| PCVX Vaxcyte | Reiterated: Buy | $89 | $67.53 | +31.79% | 28 | Nov 4, 2026 | |
| DNLI Denali Therapeutics | Reiterated: Buy | $39 | $20.33 | +91.83% | 39 | Nov 3, 2026 | |
| DRUG Bright Minds Biosciences | Reiterated: Buy | $147 → $37 | $24.11 | +53.46% | 7 | Nov 2, 2026 | |
| ABOS Acumen Pharmaceuticals | Reiterated: Buy | $8 → $1 | $0.237 | +321.94% | 31 | Nov 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.38 | +320.17% | 17 | Nov 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $27.71 | +40.74% | 33 | Nov 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.43 | +459.44% | 4 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.09 | +358.72% | 31 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.5962 | +1,577.29% | 9 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.74 | +301.07% | 3 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.20 | +185.71% | 9 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 | $27.47 | +129.34% | 13 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 → $37 | $27.80 | +33.09% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $3.33 | +380.48% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $5.69 | +602.99% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $254.87 | - | 51 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.85 | +40.35% | 17 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.636 | +1,315.09% | 33 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $15.23 | +5.06% | 28 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.13 | n/a | 32 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $200 | $4.05 | n/a | 7 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.50 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.47 | n/a | 14 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $0.000001 | n/a | 6 | Mar 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $0.7996 | n/a | 16 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.7597 | n/a | 5 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $77.93 | n/a | 20 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 → $15 | $19.75 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.23 | n/a | 5 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.63 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $216 | $9.34 | n/a | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $50 → $12 | $2.34 | n/a | 8 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.35 | n/a | 4 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $11.73 | n/a | 2 | Mar 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $38.59 | n/a | 4 | Mar 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $57 → $70 | $18.95 | n/a | 5 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $20.14 | n/a | 7 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.03 | n/a | 4 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $16 | $9.68 | n/a | 5 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $22.26 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 | $0.000001 | n/a | 3 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.5 | $0.9495 | n/a | 4 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.9965 | n/a | 9 | Jun 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.99 | n/a | 8 | May 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.99 | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $10.61 | n/a | 1 | Oct 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $39 | $4.73 | n/a | 12 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $26 | $7.02 | n/a | 4 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $12 | $21.18 | n/a | 4 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $40 | $15.32 | n/a | 5 | Oct 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $76 | $47.97 | n/a | 3 | Oct 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.51 | n/a | 17 | Oct 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $110 → $130 | $8.40 | n/a | 7 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 | $0.0006 | n/a | 1 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $38 | $3.90 | n/a | 9 | Jun 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.2 → $11 | $2.87 | n/a | 4 | Dec 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $169.32 | n/a | 1 | Mar 23, 2015 |
Tiziana Life Sciences
Nov 10, 2026
Maintained: Buy
Price Target: $7
Current: $0.6691
Upside: +946.18%
COMPASS Pathways
Nov 10, 2026
Maintained: Buy
Price Target: $25
Current: $9.18
Upside: +172.33%
Arcturus Therapeutics Holdings
Nov 6, 2026
Reiterated: Buy
Price Target: $20
Current: $9.49
Upside: +110.75%
Alector
Nov 5, 2026
Reiterated: Buy
Price Target: $6
Current: $2.46
Upside: +143.90%
Novavax
Nov 5, 2026
Reiterated: Buy
Price Target: $19
Current: $10.89
Upside: +74.47%
AC Immune
Nov 4, 2026
Reiterated: Buy
Price Target: $8
Current: $2.44
Upside: +227.87%
Vaxcyte
Nov 4, 2026
Reiterated: Buy
Price Target: $89
Current: $67.53
Upside: +31.79%
Denali Therapeutics
Nov 3, 2026
Reiterated: Buy
Price Target: $39
Current: $20.33
Upside: +91.83%
Bright Minds Biosciences
Nov 2, 2026
Reiterated: Buy
Price Target: $147 → $37
Current: $24.11
Upside: +53.46%
Acumen Pharmaceuticals
Nov 1, 2026
Reiterated: Buy
Price Target: $8 → $1
Current: $0.237
Upside: +321.94%
Nov 1, 2026
Reiterated: Buy
Price Target: $10
Current: $2.38
Upside: +320.17%
Nov 1, 2026
Reiterated: Buy
Price Target: $39
Current: $27.71
Upside: +40.74%
Oct 26, 2026
Reiterated: Buy
Price Target: $8
Current: $1.43
Upside: +459.44%
Oct 5, 2026
Reiterated: Buy
Price Target: $5
Current: $1.09
Upside: +358.72%
Sep 29, 2026
Reiterated: Buy
Price Target: $10
Current: $0.5962
Upside: +1,577.29%
Sep 28, 2026
Reiterated: Buy
Price Target: $15
Current: $3.74
Upside: +301.07%
Sep 9, 2026
Reiterated: Buy
Price Target: $12
Current: $4.20
Upside: +185.71%
Aug 25, 2026
Reiterated: Buy
Price Target: $63
Current: $27.47
Upside: +129.34%
Aug 13, 2026
Rated: Buy
Price Target: $28 → $37
Current: $27.80
Upside: +33.09%
Aug 11, 2026
Reiterated: Buy
Price Target: $16
Current: $3.33
Upside: +380.48%
Aug 5, 2026
Reiterated: Buy
Price Target: $40
Current: $5.69
Upside: +602.99%
Jul 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $254.87
Upside: -
Mar 26, 2026
Reiterated: Buy
Price Target: $4
Current: $2.85
Upside: +40.35%
Mar 17, 2026
Reiterated: Buy
Price Target: $9
Current: $0.636
Upside: +1,315.09%
Nov 17, 2025
Reiterated: Buy
Price Target: $16
Current: $15.23
Upside: +5.06%
Nov 3, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.13
Upside: n/a
Jul 21, 2025
Reiterated: Buy
Price Target: $8 → $200
Current: $4.05
Upside: n/a
May 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $2.50
Upside: n/a
Mar 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.47
Upside: n/a
Mar 19, 2024
Reiterated: Buy
Price Target: $32
Current: $0.000001
Upside: n/a
Feb 28, 2024
Reiterated: Buy
Price Target: $33
Current: $0.7996
Upside: n/a
Jan 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $0.7597
Upside: n/a
Nov 17, 2023
Rated: Hold
Price Target: n/a
Current: $77.93
Upside: n/a
Nov 14, 2023
Rated: Buy
Price Target: $32 → $15
Current: $19.75
Upside: n/a
Aug 4, 2023
Rated: Hold
Price Target: n/a
Current: $4.23
Upside: n/a
May 5, 2023
Rated: Hold
Price Target: n/a
Current: $2.63
Upside: n/a
Apr 3, 2023
Reiterated: Buy
Price Target: $216
Current: $9.34
Upside: n/a
Mar 20, 2023
Rated: Buy
Price Target: $50 → $12
Current: $2.34
Upside: n/a
Mar 20, 2023
Reiterated: Hold
Price Target: n/a
Current: $4.35
Upside: n/a
Mar 12, 2023
Rated: Buy
Price Target: $20
Current: $11.73
Upside: n/a
Mar 5, 2023
Reiterated: Buy
Price Target: $56
Current: $38.59
Upside: n/a
Mar 2, 2023
Rated: Buy
Price Target: $57 → $70
Current: $18.95
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $20.14
Upside: n/a
Oct 15, 2021
Rated: Hold
Price Target: n/a
Current: $1.03
Upside: n/a
Sep 9, 2021
Rated: Buy
Price Target: $16
Current: $9.68
Upside: n/a
Aug 6, 2021
Reiterated: Buy
Price Target: $60
Current: $22.26
Upside: n/a
Jul 6, 2021
Rated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Jun 10, 2021
Reiterated: Buy
Price Target: $5.5
Current: $0.9495
Upside: n/a
Jun 4, 2021
Rated: Hold
Price Target: n/a
Current: $0.9965
Upside: n/a
May 10, 2021
Reiterated: Hold
Price Target: n/a
Current: $1.99
Upside: n/a
Sep 23, 2020
Downgraded: Hold
Price Target: n/a
Current: $0.99
Upside: n/a
Oct 6, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $10.61
Upside: n/a
Nov 9, 2017
Reiterated: Buy
Price Target: $57 → $39
Current: $4.73
Upside: n/a
Nov 7, 2017
Reiterated: Buy
Price Target: $32 → $26
Current: $7.02
Upside: n/a
Nov 1, 2017
Reiterated: Buy
Price Target: $14 → $12
Current: $21.18
Upside: n/a
Oct 17, 2017
Reiterated: Buy
Price Target: $20 → $40
Current: $15.32
Upside: n/a
Oct 10, 2017
Reiterated: Buy
Price Target: $35 → $76
Current: $47.97
Upside: n/a
Oct 5, 2017
Reiterated: Buy
Price Target: $11
Current: $1.51
Upside: n/a
Oct 2, 2017
Rated: Buy
Price Target: $110 → $130
Current: $8.40
Upside: n/a
Jun 30, 2017
Downgraded: Hold
Price Target: $6
Current: $0.0006
Upside: n/a
Jun 21, 2017
Reiterated: Buy
Price Target: $32 → $38
Current: $3.90
Upside: n/a
Dec 22, 2016
Reiterated: Hold
Price Target: $1.2 → $11
Current: $2.87
Upside: n/a
Mar 23, 2015
Downgraded: Hold
Price Target: n/a
Current: $169.32
Upside: n/a